Ravindra K Gupta

Ravindra K Gupta, BMBCh, MA, MPH, PhD, FRCP, FRCPathRavi Gupta has been Professor of Clinical Microbiology at the Cambridge Institute for Therapeutic Immunology and Infectious Diseases since...

Read Bio

Ravindra K Gupta

Ravindra K Gupta, BMBCh, MA, MPH, PhD, FRCP, FRCPath

Ravi Gupta has been Professor of Clinical Microbiology at the Cambridge Institute for Therapeutic Immunology and Infectious Diseases since 2019. Having completed his medical undergraduate studies at Cambridge and Oxford Universities, he pursued a Masters in Public Health at Harvard as a Fulbright scholar. Upon return he trained in infectious diseases in Oxford and London, and completed his PhD at UCL on HIV-1 evasion of antiretrovirals and innate immune responses. He has worked extensively in HIV drug resistance, both at molecular and population levels, and his work demonstrating escalating global resistance led to change in WHO treatment guidelines for HIV. Whilst Professor at UCL, he led the team demonstrating HIV cure in the ‘London Patient’ – the world’s only living HIV cure, and the second recorded in history (Gupta et al, Nature 2019). In 2020 he was named as one of the 100 Most influential people worldwide by TIME Magazine. He has deployed his expertise in RNA virus genetics and biology during the COVID-19 pandemic to report the first evidence for immune escape of SARS-CoV-2 within an individual, defining the process by which new variants likely arise (Kemp et al, Nature 2021), and also reporting the first data on Pfizer BioNTech vaccine-induced antibody responses against the B.1.1.7 variant that arose in the UK (Collier et al, Nature 2021). Professor Gupta is also a co-opted member of NERVTAG, the New and Emerging Respiratory Virus Threats Group which advises the UK government on COVID-19

Elizabeth Cheung

Scmp

Elizabeth Cheung, Senior Reporter, South China Morning Post.She has been covering healthcare news for the South China Morning Post’s Hong Kong desk since 2014, and has been one of the ...

Read Bio

Sharon Peacock

Professor Sharon Peacock BM, BA, MSc, DTM&H, MRCP, MRCPath, PhD, FMedSci, CBESharon Peacock is currently Professor of Public Health and Microbiology in the Department of Medicine, Univer...

Read Bio

Sharon Peacock

Professor Sharon Peacock BM, BA, MSc, DTM&H, MRCP, MRCPath, PhD, FMedSci, CBE

Sharon Peacock is currently Professor of Public Health and Microbiology in the Department of Medicine, University of Cambridge, and Executive Director of the COVID-19 Genomics UK (COG-UK) consortium – which has generated half the global SARS-CoV-2 genomes to date. She has built her scientific career around pathogen genomics, antimicrobial resistance, and a range of tropical diseases included melioidosis, leptospirosis and rickettsial infections. Professor Peacock has published more than 450 peer reviewed papers and manages >£38M of funding. She is a Fellow of the Academy of Medical Sciences, a Fellow of the American Academy of Microbiology, and an elected Member of

EMBO. In 2015, Professor Peacock received a CBE for services to medical microbiology, and in 2018 she won the Unilever Colworth Prize for her outstanding contribution to translational microbiology.

Coronavirus Updates: Facts from Hong Kong and Beyond - Episode 30: Conversation with Prof. Sharon Peacock & Prof. Ravindra Gupta

Speakers